• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BBOX1 在癌旁组织中的高表达与肝癌患者的不良预后相关。

High expression of BBOX1 in paracancerous tissue is associated with poor prognosis in hepatocellular carcinoma patients.

机构信息

School of Clinical Medicine, Bengbu Medical University, Bengbu, China.

School of Life Science, Bengbu Medical University, No. 2600 Donghai Road, Bengbu, 233030, China.

出版信息

Sci Rep. 2024 Nov 18;14(1):28413. doi: 10.1038/s41598-024-78127-6.

DOI:10.1038/s41598-024-78127-6
PMID:39557956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11574014/
Abstract

The molecular profile of paracancerous tissue has been reported to be prognostic for recurrence in patients with different cancers. This study investigated the clinical significance of the protein expression of gamma-butyrobetaine hydroxylase 1 (BBOX1) in tumor and paracancerous tissues of hepatocellular carcinoma (HCC) patients. This study assessed the role of BBOX1 mRNA in tumor and paracancerous tissues in HCC via bioinformatics analysis. The protein levels of BBOX1 in paired tumor and paracancerous tissues from 83 HCC patients were determined by immunohistochemistry. The associations among BBOX1 protein levels, clinicopathological characteristics and the survival probability of HCC patients were also analyzed. The results revealed that BBOX1 mRNA expression was significantly lower in HCC tissues than in noncancerous tissues. HCC patients with low BBOX1 mRNA expression had a significantly poorer overall survival than those with high BBOX1 expression did. Immunohistochemical analysis of BBOX1 protein expression further confirmed that its levels were markedly lower in HCC tissues than in paracancerous tissues. High BBOX1 expression in paracancerous tissues correlated with poor overall survival and disease-free survival in HCC patients. These findings suggest that the paracancerous BBOX1 expression might be a credible indicator for overall survival or disease-free survival in HCC patients.

摘要

癌旁组织的分子特征已被报道与不同癌症患者的复发预后相关。本研究旨在探讨γ-丁羟酸脱水酶 1(BBOX1)在肝癌(HCC)患者肿瘤和癌旁组织中的蛋白表达的临床意义。本研究通过生物信息学分析评估了 BBOX1 在 HCC 肿瘤和癌旁组织中的作用。采用免疫组织化学法检测 83 例 HCC 患者配对肿瘤和癌旁组织中 BBOX1 的蛋白水平,并分析 BBOX1 蛋白水平与 HCC 患者临床病理特征及生存概率之间的关系。结果显示,BBOX1 在 HCC 组织中的表达明显低于癌旁组织。BBOX1 低表达的 HCC 患者总生存率显著低于高表达患者。BBOX1 蛋白表达的免疫组化分析进一步证实,BBOX1 在 HCC 组织中的表达明显低于癌旁组织。癌旁组织中 BBOX1 高表达与 HCC 患者的总生存率和无病生存率降低相关。这些发现表明,癌旁组织 BBOX1 的表达可能是 HCC 患者总生存率或无病生存率的可靠指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11574014/95e508f758c8/41598_2024_78127_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11574014/98f576facf3b/41598_2024_78127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11574014/72aef4672fb7/41598_2024_78127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11574014/95e508f758c8/41598_2024_78127_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11574014/98f576facf3b/41598_2024_78127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11574014/72aef4672fb7/41598_2024_78127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/354e/11574014/95e508f758c8/41598_2024_78127_Fig3_HTML.jpg

相似文献

1
High expression of BBOX1 in paracancerous tissue is associated with poor prognosis in hepatocellular carcinoma patients.BBOX1 在癌旁组织中的高表达与肝癌患者的不良预后相关。
Sci Rep. 2024 Nov 18;14(1):28413. doi: 10.1038/s41598-024-78127-6.
2
High expression of HM13 correlates with poor prognosis in hepatocellular carcinoma.HM13 的高表达与肝癌的预后不良相关。
J Mol Histol. 2024 Oct;55(5):927-936. doi: 10.1007/s10735-024-10241-1. Epub 2024 Aug 19.
3
Downregulated CMTM2 Poses Potential Clinical Significance in Hepatocellular Carcinoma.CMTM2 下调在肝细胞癌中具有潜在的临床意义。
DNA Cell Biol. 2020 Apr;39(4):683-689. doi: 10.1089/dna.2019.5237. Epub 2020 Jan 28.
4
Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.信号转导和转录激活因子4(STAT4)表达降低提示肝细胞癌预后不良且细胞增殖增强。
World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983.
5
Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.Spondin-2蛋白表达上调与肝细胞癌预后不良相关。
J Int Med Res. 2019 Feb;47(2):569-579. doi: 10.1177/0300060518803232. Epub 2018 Oct 14.
6
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.一种在肝细胞癌中上调的新型预后生物标志物SPC24。
Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.
7
Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.Gab2蛋白在肝细胞癌中的表达模式及临床意义
Clin Lab. 2016;62(6):1087-92. doi: 10.7754/clin.lab.2015.151008.
8
Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.上皮组织特异性转录因子 ESE3 在肝细胞癌中的表达及预后意义。
Int J Clin Oncol. 2020 Jul;25(7):1334-1345. doi: 10.1007/s10147-020-01675-0. Epub 2020 Apr 28.
9
Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.Chibby 和 β-连环蛋白联合预测肝细胞癌患者的临床结局。
Int J Mol Sci. 2020 Mar 17;21(6):2060. doi: 10.3390/ijms21062060.
10
Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma.TRIM3表达降低与原发性肝细胞癌患者的不良预后相关。
Med Oncol. 2014 Aug;31(8):102. doi: 10.1007/s12032-014-0102-9. Epub 2014 Jul 4.

本文引用的文献

1
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.肝细胞癌发病机制中遗传学与生物化学之间的相互作用。
Hepatol Forum. 2024 Jul 2;5(3):150-160. doi: 10.14744/hf.2023.2023.0028. eCollection 2024.
2
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.全球肝细胞癌流行病学趋势:对筛查、预防和治疗的启示。
Nat Rev Clin Oncol. 2023 Dec;20(12):864-884. doi: 10.1038/s41571-023-00825-3. Epub 2023 Oct 26.
3
Attenuation of binuclear hepatocytes in the paracancerous liver tissue is associated with short-term recurrence of hepatocellular carcinoma post-radical surgery.
双核肝细胞在癌旁肝组织中的衰减与根治性手术后肝细胞癌的短期复发有关。
FASEB J. 2023 Nov;37(11):e23271. doi: 10.1096/fj.202301219R.
4
Cancer metastasis: Molecular mechanisms and clinical perspectives.癌症转移:分子机制与临床视角。
Pharmacol Ther. 2023 Oct;250:108522. doi: 10.1016/j.pharmthera.2023.108522. Epub 2023 Sep 1.
5
Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma.肿瘤旁样本的蛋白质组学揭示了肝细胞癌中与临床相关的生物学事件。
Natl Sci Rev. 2023 Jun 2;10(8):nwad167. doi: 10.1093/nsr/nwad167. eCollection 2023 Aug.
6
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.肿瘤微环境中浸润免疫细胞对肝癌转移的影响。
Cell Oncol (Dordr). 2023 Dec;46(6):1595-1604. doi: 10.1007/s13402-023-00841-6. Epub 2023 Jul 6.
7
Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients.肿瘤旁正常组织的转录组比肿瘤组织更能预测结直肠癌患者的复发情况。
J Transl Med. 2023 Mar 21;21(1):209. doi: 10.1186/s12967-023-04053-2.
8
Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma.长链酰基辅酶 A 诱导肝癌中固有自然杀伤 T 细胞衰老。
Cancer Res. 2023 Feb 15;83(4):582-594. doi: 10.1158/0008-5472.CAN-22-2273.
9
CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma.CRIP1 通过抑制 BBOX1 介导的肉碱代谢来促进肝癌的干性。
EMBO J. 2022 Aug 1;41(15):e110218. doi: 10.15252/embj.2021110218. Epub 2022 Jul 1.
10
New dawn for cancer cell death: Emerging role of lipid metabolism.癌症细胞死亡的新曙光:脂质代谢的新兴作用。
Mol Metab. 2022 Sep;63:101529. doi: 10.1016/j.molmet.2022.101529. Epub 2022 Jun 15.